http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3894424-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6afd2c95ff62063eded320e23d028a8a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J63-008
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J63-00
filingDate 2019-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8ea7a7d6db4e72edb4a0552e5340588
publicationDate 2021-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3894424-A1
titleOfInvention Mesylate salt of an amino-lupane compound with hiv maturation inhibitory activity
abstract The present invention relates to the mesylate (CH3SO2) salt of the following compound (I).
priorityDate 2018-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID464205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3002977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23053668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226869335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226435168
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148192

Total number of triples: 34.